FI960721A - Verisuonia supistavia substituoituja dihydropyranopyridiinejä - Google Patents

Verisuonia supistavia substituoituja dihydropyranopyridiinejä Download PDF

Info

Publication number
FI960721A
FI960721A FI960721A FI960721A FI960721A FI 960721 A FI960721 A FI 960721A FI 960721 A FI960721 A FI 960721A FI 960721 A FI960721 A FI 960721A FI 960721 A FI960721 A FI 960721A
Authority
FI
Finland
Prior art keywords
6alkyl
hydrogen
pct
formula
radical
Prior art date
Application number
FI960721A
Other languages
English (en)
Swedish (sv)
Other versions
FI113773B (fi
FI960721A0 (fi
Inventor
Lommen Guy Rosalia Eugene Van
Francisco Javi Fernandez-Gadea
Jose Ignacio Andres-Gil
Maria Enc Matesanz-Ballesteros
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of FI960721A0 publication Critical patent/FI960721A0/fi
Publication of FI960721A publication Critical patent/FI960721A/fi
Application granted granted Critical
Publication of FI113773B publication Critical patent/FI113773B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
FI960721A 1993-08-19 1996-02-16 Menetelmä verisuonia supistavien substituoitujen dihydropyranopyridiinien valmistamiseksi FI113773B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP93202440 1993-08-19
EP93202440 1993-08-19
EP9402700 1994-08-12
PCT/EP1994/002700 WO1995005381A1 (en) 1993-08-19 1994-08-12 Vasoconstrictive substituted dihydropyranopyridines

Publications (3)

Publication Number Publication Date
FI960721A0 FI960721A0 (fi) 1996-02-16
FI960721A true FI960721A (fi) 1996-02-16
FI113773B FI113773B (fi) 2004-06-15

Family

ID=8214053

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960721A FI113773B (fi) 1993-08-19 1996-02-16 Menetelmä verisuonia supistavien substituoitujen dihydropyranopyridiinien valmistamiseksi

Country Status (27)

Country Link
US (1) US5691344A (fi)
EP (1) EP0714395B1 (fi)
JP (1) JP3650398B2 (fi)
KR (1) KR100330697B1 (fi)
CN (1) CN1051085C (fi)
AT (1) ATE178330T1 (fi)
AU (1) AU684819B2 (fi)
BR (1) BR9407298A (fi)
CA (1) CA2168022C (fi)
CZ (1) CZ286645B6 (fi)
DE (1) DE69417560T2 (fi)
DK (1) DK0714395T3 (fi)
ES (1) ES2132424T3 (fi)
FI (1) FI113773B (fi)
GR (1) GR3029924T3 (fi)
HU (1) HU228673B1 (fi)
IL (1) IL110688A (fi)
MY (1) MY111419A (fi)
NO (1) NO315001B1 (fi)
NZ (1) NZ271383A (fi)
PL (1) PL177516B1 (fi)
RO (1) RO116729B1 (fi)
RU (1) RU2135501C1 (fi)
SI (1) SI0714395T1 (fi)
SK (1) SK282108B6 (fi)
WO (1) WO1995005381A1 (fi)
ZA (1) ZA946268B (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6818659B2 (en) 2001-11-06 2004-11-16 Bristol-Myers Squibb Pharma, Inc. (2S)-2-amino-4-(2-amino-(3,4,5,6-tetrahydropyrimidin-4-yl) butanoyl and its use in cyclic and acyclic peptides
CN109476675B (zh) * 2016-07-01 2022-12-09 爱尔兰詹森科学公司 用于治疗病毒性感染的二氢吡喃并嘧啶衍生物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU576868B2 (en) * 1984-06-11 1988-09-08 E.I. Du Pont De Nemours And Company Thiophene and pyridine sulfonamides
FR2615191B1 (fr) * 1987-05-16 1991-01-11 Sandoz Sa Nouveaux benzo(b)pyrannes et pyrannopyridines, leur preparation et leur utilisation comme medicaments
DE3901814A1 (de) * 1988-07-28 1990-02-01 Bayer Ag Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
US5140031A (en) * 1989-05-31 1992-08-18 E. R. Squibb & Sons, Inc. Pyranyl cyanoguanidine derivatives
US5250450A (en) * 1991-04-08 1993-10-05 Micron Technology, Inc. Insulated-gate vertical field-effect transistor with high current drive and minimum overlap capacitance
DE4120322A1 (de) * 1991-06-20 1992-12-24 Bayer Ag Aminomethyl-substituierte 2,3-dihydropyrano(2,3-b)pyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
SI9300097B (en) * 1992-02-27 2001-12-31 Janssen Pharmaceutica Nv (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines

Also Published As

Publication number Publication date
SK19496A3 (en) 1997-02-05
RO116729B1 (ro) 2001-05-30
CN1051085C (zh) 2000-04-05
ES2132424T3 (es) 1999-08-16
HUT74676A (en) 1997-01-28
US5691344A (en) 1997-11-25
GR3029924T3 (en) 1999-07-30
EP0714395B1 (en) 1999-03-31
ATE178330T1 (de) 1999-04-15
AU684819B2 (en) 1998-01-08
HU9600374D0 (en) 1996-04-29
HU228673B1 (en) 2013-05-28
SK282108B6 (sk) 2001-11-06
RU2135501C1 (ru) 1999-08-27
ZA946268B (en) 1996-02-19
NO960647L (no) 1996-02-19
DE69417560T2 (de) 1999-11-11
NO960647D0 (no) 1996-02-19
PL313080A1 (en) 1996-05-27
CN1129943A (zh) 1996-08-28
CZ37396A3 (en) 1996-05-15
AU7499594A (en) 1995-03-14
CA2168022A1 (en) 1995-02-23
CZ286645B6 (cs) 2000-05-17
DE69417560D1 (de) 1999-05-06
WO1995005381A1 (en) 1995-02-23
FI113773B (fi) 2004-06-15
JP3650398B2 (ja) 2005-05-18
BR9407298A (pt) 1996-10-01
MY111419A (en) 2000-04-29
DK0714395T3 (da) 1999-10-11
PL177516B1 (pl) 1999-12-31
NO315001B1 (no) 2003-06-23
KR100330697B1 (ko) 2002-10-04
EP0714395A1 (en) 1996-06-05
CA2168022C (en) 2006-11-21
FI960721A0 (fi) 1996-02-16
IL110688A (en) 1998-10-30
JPH09501669A (ja) 1997-02-18
IL110688A0 (en) 1994-11-11
SI0714395T1 (en) 1999-08-31
NZ271383A (en) 1997-05-26

Similar Documents

Publication Publication Date Title
ATE165091T1 (de) Gefässverengende substituierte aryloxyalkyldiamine
DE69008366T2 (de) 2-Aminopyrimidinon-Derivate.
ATE59644T1 (de) 5,6-dihydro-2-(substituiertes phenyl)-1,2,4triazin-3,5(2h,4h)-dione.
PT82480A (en) Process for the preparation of 2-amino thiazoles n-substituted and for the corresponding pharmaceutical compositions
DE69616825D1 (en) Triazolone als apolipoprotein-b synthese ihibitoren
FI960721A0 (fi) Verisuonia supistavia substituoituja dihydropyranopyridiinejä
MY113426A (en) Vasoconstrictive substituted 2, 3-dihydro-1, 4- dioxinopyridines
CA2211889A1 (en) Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines
ATE170848T1 (de) Oxazolidin verbindungen und ihre verwendung als arzneimittel
MX9703074A (es) Inhibidores de sintesis de apoliproteina-b.

Legal Events

Date Code Title Description
MA Patent expired